RenovoRx share price logo

RenovoRx

NASDAQ: RNXT

$1.14

-0.05

(-4.20%)

as on

RenovoRx Stock Performance

as on October 17, 2026 at 2:15 pm IST

  • Day's High

    $1.14
    $1.21

    6.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.70
    $2.59
    downward going graph

    38.54%

    Downside

    127.19%

    Upside

    downward going graph

RenovoRx share price movements today

Previous Close
$1.19
Open
$1.21
Volume
390.2K
Market Cap
$53.7M
Day's Low - High
$1.14 - $1.21
52 Week Low - High
$0.70 - $2.59

RenovoRx Historical Returns

1 Month Return
-34.1 %
3 Month Return
+ 31.75 %
1 Year Return
+ 1.79 %
3 Year Return
+ 2.7 %
5 Year Return
-80.94 %

RenovoRx Stock Fundamentals & Key Indicators

Check RenovoRx market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$53.7M

EPS (TTM)

-0.3163

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.76

Industry PE ratio

-3.02

PEG Ratio

-0.20

EBITDA

-12.3M

Revenue (TTM)

2.0M

Profit Margin

84.41%

Return On Equity TTM

-145.63%

RenovoRx vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RenovoRx with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$53.7M-80.94%-3.7684.41%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for RenovoRx Stock including INR - Dollar returns

The RenovoRx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

RenovoRx investment value today

Current value as on today

₹1,09,992

Returns

₹9,992

(+9.99%)

Returns from RenovoRx Stock

₹1,786 (+1.79%)

Dollar Impact

₹8,207 (+8.21%)

Analyst Recommendation on RenovoRx Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for RenovoRx. Average target price of $7.12

RenovoRx Share Price Target

Get share price movements and forecasts by analysts on RenovoRx.

What analysts predicted

83.99%UPSIDE

Target Price

$7.12

Current Price

$1.14

Analyzed by

2 Analysts

High

$8

Target

$7.12

Low

$3

RenovoRx target price $7.12, a slight upside of 83.99% compared to current price of $1.14. According to 2 analysts rating.

Indian Investors' Interest in RenovoRx Stock

Search interest for RenovoRx Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-71% versus previous 30 day period

RenovoRx Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
0
0
0
0
0
0
Gross Profit
-
-
-
-
0
0
0
0
0
0
Operating Income
-1
-2
-3
-2
-3
-2
-3
-3
-3
-3
EBITDA
-3
-1
-2
-2
-2
-2
-2
-2
-3
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
-
-
-
0
0
0
0
0
0
Income Before Tax
-3
-1
-2
-2
-2
-2
-2
-2
-3
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-1
-2
-2
-2
-2
-2
-2
-3
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
52.28%
63.98%
80.08%
88.24%
85.08%
84.27%

RenovoRx Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
-
-
-
-
0
1
Gross Profit
-
-
-
-
-
0
0
Operating Income
-3
-3
-5
-9
-11
-10
-12
EBITDA
-3
-
-5
-9
-10
-8
-11
Interest Expense
-
0
0
0
0
-
-
Depreciation
-
3
0
0
0
-
0
Income Before Tax
-3
-3
-6
-9
-10
-8
-11
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-3
-3
-6
-9
-10
-8
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
70.88%

RenovoRx Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-1
-2
-2
-2
-2
-2
-2
-3
-2
Operating Cash Flow
-2
-2
-2
-2
-3
-2
-2
-3
-3
-2
Investing Cash Flow
-
-
-
-
0
-
-
-
-
0
Financing Cash Flow
-
5
9
0
10
0
-
-
9
0
Change in Cash
-2
3
7
-2
7
-2
-2
-3
5
-2

RenovoRx Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-3
-3
-6
-9
-10
-8
-11
Operating Cash Flow
-3
-3
-5
-8
-10
-9
-10
Investing Cash Flow
0
-
0
-2
2
0
0
Financing Cash Flow
-
3
19
0
5
15
10
Change in Cash
-3
0
13
-10
-3
5
0

Global Institutional Holdings in RenovoRx

Check out the Institutions with significant holdings in RenovoRx.

Funds
Holdings
Vanguard
3.51%
VANGUARD INDEX FUNDS
3.14%
Fidelity Concord Street Trust
0.70%
VANGUARD VALLEY FORGE FUNDS
0.07%
Victory Portfolios III
0.00%

RenovoRx News & Key Events

  • img

    Today's Timeline - 01 October

    Thu, 06:00 PM

    -

    RenovoRx publishes peer-reviewed case series on TAMP platform's effectiveness in treating locally advanced pancreatic cancer.

Insights on RenovoRx

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 153.5% return, outperforming this stock by 147.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 736.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, RNXT stock has moved down by -32.5%

About RenovoRx

RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
OrganisationRenovoRx
Headquarters4546 El Camino Real, Mountain View, CA, 94040, US
IndustryBiotechnology
CEOShaun R. Bagai

Key Management of RenovoRx

Name

Title

Dr. Ramtin Agah M.D.

Founder, Executive Chairman & Chief Medical Officer

Mr. Shaun R. Bagai

CEO, Secretary & Director

Mr. Ronald B. Kocak CPA, CGMA

VP of Finance & Controller

Mr. Mark Voll

CFO & Principal Accounting Officer

Mr. Tom Kelly

Vice President of Quality & Operations

Mr. Phil Stocton

Vice President of Sales & Market Development

Ms. Leesa Gentry

Chief Clinical Officer

FAQs

What is RenovoRx share price today?

RenovoRx share price today is $1.14 as on at the close of the market. RenovoRx share today touched a day high of $1.21 and a low of $1.14.

What is the 52 week high and 52 week low for RenovoRx share?

RenovoRx share touched a 52 week high of $2.59 on and a 52 week low of $0.70 on . RenovoRx stock price today i.e. is closed at $1.14,which is 55.98% down from its 52 week high and 62.72% up from its 52 week low.

What is RenovoRx's market capitalisation today?

RenovoRx market capitalisation is $0.00T as on .

How to invest in RenovoRx Stock (RNXT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for RenovoRx on INDmoney app. Click on Buy button.

What is the minimum amount required to buy RenovoRx Stock (RNXT) from India?

Indian investors can start investing in RenovoRx (RNXT) shares with as little as ₹94.959999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in RenovoRx stock (as per the Rupee-Dollar exchange rate as on ). Based on RenovoRx share’s latest price of $1.14 as on October 17, 2026 at 8:45 am IST, you will get 8.7719 shares of RenovoRx. Learn more about fractional shares .

What are the returns that RenovoRx has given to Indian investors in the last 5 years?

RenovoRx stock has given -80.94% share price returns and 26.39% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?